Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection

Experimental Neurology

Volumn 183, Issue 2, 2003, Pages 367-378

  Melchior, Benoît ^a   Nerrière Daguin, Véronique ^a   Laplaud, David A ^a,b   Rémy, Séverine ^a   Wiertlewski, Sandrine ^b   Neveu, Isabelle ^a   Naveilhan, Philippe ^a   Meakin, Susan O ^c   Brachet, Philippe ^a  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Alzheimer's disease; Cell death; Gene therapy; Nerve growth factor; Neurotrophic factor; Neurotrophin; Parkinson's disease

Indexed keywords

COMPLEMENTARY DNA; INDIUM; MYC PROTEIN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; TYROSINE 3 MONOOXYGENASE; VIRUS VECTOR;

ADENOVIRUS; ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN NERVE CELL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; FIBROBLAST; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MESENCEPHALON; MOLECULAR CLONING; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; SUBSTANTIA NIGRA; THALAMUS; VIRUS RECOMBINANT;

EID: 0141672053     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00137-7     Document Type: Article

References (72)

1. Allsopp T.E., Robinson M., Wyatt S., Davies A.M. Ectopic trkA expression mediates a NGF survival response in NGF-independent sensory neurons but not in parasympathetic neurons. J. Cell. Biol. 123:1993;1555-1566.
2. Allsopp T.E., Robinson M., Wyatt S., Davies A.M. TrkA mediates an NGF survival response in NGF-independent sensory neurons but not in parasympathetic neurons. Gene Ther. 1:1994;S59.
3. Altar C.A., Armanini M., Dugich-Djordjevic M., Bennett G.L., Williams R., Feinglass S., Anicetti V., Sinicropi D., Bakhit C. Recovery of cholinergic phenotype in the injured rat neostriatum roles for endogenous and exogenous nerve growth factor . J. Neurochem. 59:1992;2167-2177.
4. Ayer-LeLievre C., Olson L., Ebendal T., Seiger A., Persson H. Expression of the beta-nerve growth factor gene in hippocampal neurons. Science. 240:1988;1339-1341.
5. Beckstead R.M. The thalamostriatal projection in the cat. J. Comp. Neurol. 223:1984;313-346.
6. Berendse H.W., Groenewegen H.J. Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J. Comp. Neurol. 299:1990;187-228.
7. Bjorklund A., Kirik D., Rosenblad C., Georgievska B., Lundberg C., Mandel R.J. Towards a neuroprotective gene therapy for Parkinson's disease use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model . Brain Res. 886:2000;82-98.
8. Boissiere F., Hunot S., Faucheux B., Hersh L.B., Agid Y., Hirsch E.C. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 8:1997;1-8.
9. Bradbury E.J., King V.R., Simmons L.J., Priestley J.V., McMahon S.B. NT-3 but not BDNF, prevents atrophy and death of axotomized spinal cord projection neurons. Eur. J. Neurosci. 10:1998;3058-3068.
10. Chao M.V., Hempstead B.L. p75 and Trk a two-receptor system . Trends Neurosci. 18:1995;321-326.
11. Curtis R., Adryan K.M., Stark J.L., Park J.S., Compton D.L., Weskamp G., Huber L.J., Chao M.V., Jaenisch R., Lee K.F., et al. Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins. Neuron. 14:1995;1201-1211.
12. Davidson B.L., Stein C.S., Heth J.A., Martins I., Kotin R.M., Derksen T.A., Zabner J., Ghodsi A., Chiorini J.A. Recombinant adeno-associated virus type 2, 4, and 5 vectors transduction of variant cell types and regions in the mammalian central nervous system . Proc. Natl. Acad. Sci. USA. 97:2000;3428-3432.
13. DiStefano P.S., Friedman B., Radziejewski C., Alexander C., Boland P., Schick C.M., Lindsay R.M., Wiegand S.J. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron. 8:1992;983-993.
14. Du B., Wu P., Boldt-Houle D.M., Terwilliger E.F. Efficient transduction of human neurons with an adeno-associated virus vector. Gene Ther. 3:1996;254-261.
15. Frim D.M., Uhler T.A., Short M.P., Ezzedine Z.D., Klagsburn M., Breakfield X.O., Isacson O. Effect of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. NeuroReport. 4:1993;367-370.
16. German D.C., Manaye K.F. Midbrain dopaminergic neurons (nuclei A8, A9 and A10) three dimensional reconstruction in the rat . J. Comp. Neurol. 331:1993;297-309.
17. Grimm D., Kern A., Rittner K., Kleinschmidt J.A. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9:1998;2745-2760.
18. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6:1986;2155-2162.
19. Hirsch E.C., Faucheux B., Damier P., Mouatt-Prigent A., Agid Y. Neuronal vulnerability in Parkinson's disease. J. Neural Transm. Suppl. 50:1997;79-88.
20. Holtzman D.M., Kilbridge J., Li Y., Cunningham E.T. Jr., Lenn N.J., Clary D.O., Reichardt L.F., Mobley W.C. TrkA expression in the CNS evidence for the existence of several novel NGF-responsive CNS neurons . J. Neurosci. 15:1995;1567-1576.
21. Holtzman D.M., Li Y., Parada L.F., Kinsman S., Chen C.K., Valletta J.S., Zhou J., Long J.B., Mobley W.C. p140trk mRNA marks NGF-responsive forebrain neurons evidence that trk gene expression is induced by NGF . Neuron. 9:1992;465-478.
22. Houlgatte R., Mallat M., Brachet P., Prochiantz A. Secretion of nerve growth factor in cultures of glial cells and neurons derived from different regions of the mouse brain. J. Neurosci. Res. 24:1989;143-152.
23. Hyman C., Juhasz M., Jackson C., Wright P., Ip N., Lindsay R. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, abd NT-4/5 on cultured dopaminergic and gabaergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
24. Kaplan D.R., Hempstead B.L., Martin-Zanca D., Chao M.V., Parada L.F. The trk proto-oncogene product a signal transducing receptor for nerve growth factor . Science. 252:1991;554-558.
25. Kaplan R.D., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10:2000;381-391.
26. Klein R., Jing S.Q., Nanduri V., O'Rourke E., Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell. 65:1991;189-197.
27. Klein R.L., Hirko A.C., Meyers C.A., Grimes J.R., Muzyczka N., Meyer E.M. NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats. Brain Res. 875:2000;144-151.
28. Knusel B., Winslow J.W., Rosenthal A., Burton L.E., Seid D.P., Nikolics K., Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA. 88:1991;961-965.
29. Korsching S., Auburger G., Heumann R., Scott J., Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J. 4:1985;1389-1393.
30. Kramer B.M.R., Van Der Zee C.E.E., Hagg T. p75 nerve growth factor receptor is important for retrograde transport of neurotrophins in adult cholinergic basal forebrain neurons. Neuroscience. 94:1999;1163-1172.
31. Lo W.D., Qu G., Sferra T.J., Clark R., Chen R., Johnson P.R. Adeno-associated virus-mediated gene transfer to the brain duration and modulation of expression . Hum. Gene Ther. 10:1999;201-213.
32. Loeb D.M., Maragos J., Martin-Zanca D., Chao M.V., Parada L.F., Greene L.A. The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell. 66:1991;961-966.
33. MacDonald J.I., Verdi J.M., Meakin S.O. Activity-dependent interaction of the intracellular domain of rat trkA with intermediate filament proteins, the beta-6 proteasomal subunit, Ras-GRF1, and the p162 subunit of eIF3. J. Mol. Neurosci. 13:1999;141-158.
34. MacInnis B.L., Campenot R.B. Retrograde support of neuronal survival without retrograde transport of nerve growth factor. Science. 295:2002;1536-1539.
35. Maliartchouk S., Feng Y., Debeir T., Cuello A.C., Burges K., Saragovi H.U. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Mol. Pharmacol. 57:2000;385-391.
36. Mandel R.J., Spratt S.K., Snyder R.O., Leff S.E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA. 94:1997;14083-14088.
37. Martinez-Serrano A., Lundberg C., Horellou P., Fischer W., Bentlage C., Campbell K., McKay R.D., Mallet J., Bjorklund A. CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain complete rescue of axotomized cholinergic neurons after transplantation into the septum . J. Neurosci. 15:1995;5668-5680.
38. McAllister A.K., Katz L.C., Lo D.C. Opposing roles of endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron. 18:1997;767-778.
39. Meakin S.O., Gryz E.A., MacDonald J.I. A kinase insert isoform of rat TrkA supports nerve growth factor-dependent cell survival but not neurite outgrowth. J. Neurochem. 69:1997;954-967.
40. Meakin S.O., Suter U., Drinkwater C.C., Welcher A.A., Shooter E.M. The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc. Natl. Acad. Sci. USA. 89:1992;2374-2378.
41. Menei P., Pean J.M., Nerriere-Daguin V., Jollivet C., Brachet P., Benoit J.P. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage. Exp. Neurol. 161:2000;259-272.
42. Mobley W.C., Rutkowski J.L., Tennekoon G.I., Buchanan K., Johnston M.V. Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science. 229:1985;284-287.
43. Mufson E.J., Kroin J.S., Liu Y.T., Sobreviela T., Penn R.D., Miller J.A., Kordower J.H. Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons . Neuroscience. 71:1996;179-191.
44. Mufson E.J., Kroin J.S., Sobreviela T., Burke M.A., Kordower J.H., Penn R.D., Miller J.A. Intrastriatal infusions of brain-derived neurotrophic factor retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat . Exp. Neurol. 129:1994;15-26.
45. Mufson E.J., Li J.M., Sobreviela T., Kordower J.H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. NeuroReport. 8:1996;25-29.
46. Naveilhan P., Neveu I., Baudet C., Funakoshi H., Wion D., Brachet P., Metsis M. 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. Brain Res. Mol. Brain Res. 41:1996;259-268.
47. Numan S., Seroogy K.B. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons a double-label in situ hybridization study . J. Comp. Neurol. 403:1999;295-308.
48. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, Sydney.
49. Rennert P.D., Heinrich G. Nerve growth factor mRNA in brain localization by in situ hybridization . Biochem. Biophys. Res. Commun. 138:1986;813-818.
50. Riccio A., Pierchala B.A., Ciarallo C.L., Ginty D.D. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science. 277:1997;1097-1100.
51. Rosenberg M.B., Friedmann T., Robertson R.C., Tuszynski M., Wolff J.A., Breakefield X.O., Gage F.H. Grafting genetically modified cells to the damaged brain restorative effects of NGF expression . Science. 242:1988;1575-1578.
52. Salehi A., Verhaagen J., Dijkhuizen P.A., Swaab D.F. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75:1996;373-387.
53. Salvetti A., Oreve S., Chadeuf G., Favre D., Cherel Y., Champion-Arnaud P., David-Ameline J., Moullier P. Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 9:1998;695-706.
54. Saporito M.S., Wilcox H.M., Hartpence K.C., Lewis M.F., Vaught J.L., Carswell S. Pharmacological induction of nerve growth factor mRNA in adult brain. Exp. Neurol. 123:1993;295-302.
55. Sauer H., Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine a combined retrograde tracing and immunocytochemical study in the rat . Neuroscience. 59:1994;401-415.
56. Schwab M.E., Otten U., Agid Y., Thoenen H. Nerve growth factor (NGF) in the rat CNS absence of specific retrograde axonal transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra . Brain Res. 168:1979;473-483.
57. Seiler M., Schwab M.E. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300:1984;33-39.
58. Senut M.C., Lamour Y., Lee J., Brachet P., Dicou E. Neuronal localization of the nerve growth factor precursor-like immunoreactivity in the rat brain. Int. J. Dev. Neurosci. 8:1990;65-80.
59. Smith Y., Kieval J.Z. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci. 23:2000;S28-33.
60. Spranger M., Lindholm D., Bandtlow C., Heumann R., Gnahn H., Naher-Noe M., Thoenen H. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo . Eur. J. Neurosci. 2:1990;69-76.
61. Stephens R.M., Loeb D.L., Copeland T.D., Pawson T., Greene L.A., Kaplan D.R. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gammal to mediate NGF responses. Neuron. 12:1994;691-705.
62. Stromberg I., Wetmore C.J., Ebendal T., Ernfors P., Persson H., Olson L. Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J. Neurosci. Res. 25:1990;405-411.
63. Tenenbaum L., Jurysta F., Stathopoulos A., Puschban Z., Melas C., Hermens W.T., Verhaagen J., Pichon B., Velu T., Levivier M. Tropism of AAV-2 vectors for neurons of the globus pallidus. NeuroReport. 11:2000;2277-2283.
64. Tsui-Pierchala B.A., Ginty D.D. Characterization of an NGF-P-TrkA retrograde-signaling complex and age-dependent regulation of TrkA phosphorylation in sympathetic neurons. J. Neurosci. 19:1999;8207-8218.
65. Tuszynski M.H. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons. Cell Transplant. 9:2000;629-636.
66. Venero J.L., Hefti F., Beck K.D. Retrograde transport of nerve growth factor from hippocampus and amygdala to trkA messenger RNA expressing neurons in paraventricular and reuniens nuclei of the thalamus. Neuroscience. 64:1995;855-860.
67. Watson F.L., Heerssen H.M., Moheban D.B., Lin M.Z., Sauvageot C.M., Bhattacharyya A., Pomeroy S.L., Segal R.A. Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J. Neurosci. 19:1999;7889-7900.
68. Williams L.R., Varon S., Peterson G.M., Wictorin K., Fischer W., Bjorklund A., Gage F.H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA. 83:1986;9231-9235.
69. Wion D., MacGrogan D., Neveu I., Houlgatte R., Brachet P. 1, 25-dihydroxyvitamine D3 is a potent inducer of nerve growth factor synthesis. J. Neurosci. Res. 28:1991;110-114.
70. Yamada M., Numakawa T., Koshimizu H., Tanabe K., Wada K., Koizumi S., Hatanaka H. Distinct usage of phopholipase C gamma and She in intracellular signaling stimulated by neurtrophins. Brain Res. 955:2002;183-190.
71. Yano H., Lee F.S., Kong H., Chuang J., Arevalo J., Perez P., Sung C., Chao M.V. Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor. J. Neurosci. 21:2001;RC125.
72. Zolotukhin S., Byrne B.J., Mason E., Zolotukhin I., Potter M., Chesnut K., Summerford C., Samulski R.J., Muzyezka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene. Ther. 6:1999;973-985.